Home Forums Melanoma Diagnosis: Stage IV Genentech PDL1 trial

  • This topic is empty.
Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #20774
    jamesa
    Participant

    Genentech recently updated their trial to increase enrollments & more locations including Europe. Increasing the enrollment & adding more locations could be an indication that this drug (MPDL3280A) is getting a good objective reaponse rate

    Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors

    http://clinicaltrials.gov/ct2/show/NCT01375842

    #57601
    Catherine Poole
    Keymaster

    Thanks James, should be an interesting trial. I’ve not heard anything definitive about this therapy. Also, GSK has a PD1 moving slowly into the pipeline. These are good trials to get into as far as I can tell. Thanks for posting!

Viewing 2 posts - 1 through 2 (of 2 total)
  • The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.